Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Oliveras

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Chemical Communications (Cambridge, England)|November 25, 2022
Enzyme self-label-bound ATTO700 in single-molecule and super-resolution microscopyMichael Trumpp, Anna Oliveras, Hannes Gonschior, et al.
Science Advances|April 10, 2020
The unconventional biogenesis of Kv7.1-KCNE1 complexesAnna Oliveras, Clara Serrano-Novillo, Cristina Moreno, et al.
Medicina Clinica|May 29, 2009
[Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension]Pedro Armario, Anna Oliveras, Raquel Hernández Del Rey, et al.
Biomedical Chromatography : BMC|April 16, 2014
Determination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factorsSamanta Yubero-Lahoz, Joan Rodríguez, Anna Faura, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 26, 2025
Efficacy and safety of PCSK9 inhibitors in real lifeAntón González-Guerrero, Eugenia Navarrete-Rouco, David Benaiges, et al.
American Journal of Hypertension|September 22, 2016
Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure VariabilityAlejandro de la Sierra, Julia Pareja, Pedro Armario, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 31, 2024
Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trialAnna Oliveras, Susana Vázquez, María Victoria Vega, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 10, 2018
Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) studyAnna Oliveras, Pedro Armario, Laia Sans, et al.
Scientific Reports|May 12, 2026
Anatomically guided latent diffusion for high-resolution 3D chest CT synthesisAnna Oliveras, Roger Marí, Rafael Redondo, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2024
Resistant Hypertension and Mortality: An Observational Cohort StudyAlejandro de la Sierra, Luis M Ruilope, Natalie Staplin, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Chemical Communications (Cambridge, England)|November 25, 2022
Enzyme self-label-bound ATTO700 in single-molecule and super-resolution microscopyMichael Trumpp, Anna Oliveras, Hannes Gonschior, et al.
Science Advances|April 10, 2020
The unconventional biogenesis of Kv7.1-KCNE1 complexesAnna Oliveras, Clara Serrano-Novillo, Cristina Moreno, et al.
Medicina Clinica|May 29, 2009
[Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension]Pedro Armario, Anna Oliveras, Raquel Hernández Del Rey, et al.
Biomedical Chromatography : BMC|April 16, 2014
Determination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factorsSamanta Yubero-Lahoz, Joan Rodríguez, Anna Faura, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 26, 2025
Efficacy and safety of PCSK9 inhibitors in real lifeAntón González-Guerrero, Eugenia Navarrete-Rouco, David Benaiges, et al.
American Journal of Hypertension|September 22, 2016
Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure VariabilityAlejandro de la Sierra, Julia Pareja, Pedro Armario, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 31, 2024
Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trialAnna Oliveras, Susana Vázquez, María Victoria Vega, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 10, 2018
Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) studyAnna Oliveras, Pedro Armario, Laia Sans, et al.
Scientific Reports|May 12, 2026
Anatomically guided latent diffusion for high-resolution 3D chest CT synthesisAnna Oliveras, Roger Marí, Rafael Redondo, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2024
Resistant Hypertension and Mortality: An Observational Cohort StudyAlejandro de la Sierra, Luis M Ruilope, Natalie Staplin, et al.
Pageof 9